The effect of anti-CD4 monoclonal antibody treatment on immunopathological changes in psoriatic skin
- 1 February 1994
- journal article
- Published by Elsevier in Journal of Dermatological Science
- Vol. 7 (1), 1-13
- https://doi.org/10.1016/0923-1811(94)90016-7
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- Down-regulation of lymphocyte CD4 antigen expression by administration of anti-CD4 monoclonal antibodyClinical Immunology and Immunopathology, 1992
- Anti-CD4 monoclonal antibody therapy in severe psoriasisJournal of Autoimmunity, 1992
- CD4 Antibody Therapy and Cyclosporin A Differentially Affect HLA-DR and ICAM-1 Expression in Psoriatic SkinJournal of Investigative Dermatology, 1992
- Cyclosporin A Suppresses ICAM-1 Expression by Papillary Endothelium in Healing Psoriatic PlaquesJournal of Investigative Dermatology, 1991
- Interactions of epidermal cells and T cells in inflammatory skin diseasesJournal of the American Academy of Dermatology, 1990
- Cyclosporine A in the Treatment of Psoriasis: A Clinical and Mechanistic PerspectiveJournal of Investigative Dermatology, 1990
- Lymphocyte Trafficking in Psoriasis: A New Perspective Emphasizing the Dermal Dendrocyte with Active Dermal Recruitment Mediated Via Endothelial Cells Followed by Intra-Epidermal T-Cell ActivationJournal of Investigative Dermatology, 1990
- Remission of psoriatic lesions with muromonab-CD3 (Orthoclone OKT3) treatmentJournal of the American Academy of Dermatology, 1989
- A study of local immunity in psoriasisBritish Journal of Dermatology, 1988
- Psoriasis: a disease of abnormal Keratinocyte proliferation induced by T lymphocytesImmunology Today, 1986